Khoramnia, Ramin

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

Heier, J. S., Khanani, A. M., Quezada Ruiz, C., Basu, K., Ferrone, P. J., Brittain, C., Figueroa, M. S., Lin, H., Holz, F. G., Patel, V., et al. (2022) · The Lancet

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 785

Comparison of different excimer laser ablation frequencies (50, 200, and 500 Hz)

Winkler von Mohrenfels, C., Khoramnia, R., & Lohmann, C.-P. (2009) · Graefe's Archive for Clinical and Experimental Ophthalmology

Corneal surgery and disordersCorneal Surgery and Treatments

Cited by 19